Morphologic patterns of human endometrial epithelium in women with uterine myomata treated with leuprorelin acetate

Other OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Leuprorelin acetate treatment induced a uniform regression of the uterine mucosa after six months, but a near-normal endometrium was observed after only two months.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

AIM: We studied morphologic modifications of the endometrium induced by leuprorelin acetate, a gonadotropin-releasing hormone agonist, in women with uterine myomata. METHODS: Transmission and scanning electron microscopy observations were performed after 2 or 6 cycles of therapy (every 28 days). RESULTS: A near-normal endometrium was observed after 2 months of therapy, while treatment with 6 cycles of leuprorelin acetate induced a uniform morphologic regression of the uterine mucosa. CONCLUSIONS: The study demonstrates that leuprorelin acetate induces a unique and time-dependent regression of the endometrial mucous membrane.

My notes (saved in your browser only)

MeSH descriptors

Antineoplastic Agents, Hormonal Endometrium Gonadotropin-Releasing Hormone Leiomyoma Leuprolide Uterine Neoplasms Adult Antineoplastic Agents, Hormonal Endometrium Endometrium Endometrium Female Gonadotropin-Releasing Hormone Humans Leiomyoma Leiomyoma Leiomyoma Leuprolide Microscopy, Electron, Scanning Microscopy, Electron, Transmission

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (19)

Source provenance

openalex
last seen: 2026-05-11T06:12:37.668444+00:00
pubmed
last seen: 2026-10-08T21:07:04.513278+00:00
unpaywall
last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0 · commercial use OK